# Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)

> **NCT03297281** · NA · RECRUITING · sponsor: **Clinique Pasteur** · enrollment: 389 (estimated)

## Conditions studied

- Benign Prostatic Hyperplasia
- Anticoagulant Adverse Reaction

## Interventions

- **OTHER:** Maintenance of OAC in surgery of BPH by PVP.
- **OTHER:** Discontinuation of OAC in surgery of BPH by PVP.

## Key facts

- **NCT ID:** NCT03297281
- **Lead sponsor:** Clinique Pasteur
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-10-30
- **Primary completion:** 2027-11-30
- **Final completion:** 2028-05-31
- **Target enrollment:** 389 (ESTIMATED)
- **Last updated:** 2026-03-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03297281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03297281, "Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03297281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*